Hepatitis C Virus Infection Among Hematopoietic Cell Transplant Donors and Recipients

Publication Date: August 6, 2015
Last Updated: March 14, 2022

Recommendations

Natural History of HCV Infection in HCT Recipients

In all HCT survivors with active HCV infection, cofactors that can lead to fibrosis should be addressed. Patients should be counseled to avoid excessive weight gain, ethanol and medications or herbal supplements that are hepatotoxic, as well as on treatment of other causes of liver disease (nonalcoholic fatty liver disease, hepatitis B virus, HIV, and extrahepatic obstruction), (CI)
701

Overview

Title

Hepatitis C Virus Infection Among Hematopoietic Cell Transplant Donors and Recipients

Authoring Organization